Automated UHPLC method development for mebendazole and related impurities, from method scouting to robustness testing

Importance of the Topic

Automated UHPLC method development streamlines the creation of reliable analytical protocols for pharmaceutical compounds. By reducing manual intervention and accelerating parameter optimization, this approach enhances reproducibility, lowers costs, and supports rapid regulatory compliance for active pharmaceutical ingredients and their impurities.

Objectives and Study Overview

This study demonstrates a fully automated workflow for developing an UHPLC method to separate mebendazole and its related impurities. Key aims included systematic scouting of chromatographic conditions, iterative optimization of critical parameters, and comprehensive robustness testing to ensure method stability.

Methodology and Instrumentation

An end-to-end automated workflow was implemented using the Vanquish Flex UHPLC system coupled with ChromSword Chromeleon Connect software. Method scouting screened multiple columns, mobile phases, pH values, and organic solvents. Rapid and fine optimizations adjusted gradient profiles, column temperature, and flow rate. Robustness was assessed using a Plackett-Burman design across defined parameter ranges.

Instrumentation

• Vanquish Quaternary Flex UHPLC system with Quaternary Pump and Diode Array Detector
• Automated Viper Method Scouting kit and switching valves
• ChromSword Chromeleon Connect integrated with Chromeleon 7.3 CDS

Main Results and Discussion

During scouting, the Hypersil GOLD column with 20 mM ammonium acetate buffer (pH 4.7) and acetonitrile was selected for the highest peak count and resolution. Rapid optimization achieved baseline separation of all impurities within 13 minutes and critical peak pair resolution above 3.15. Fine optimization with a linear gradient further reduced analysis time to under 11 minutes while maintaining tailing factors below 1.2. Robustness testing demonstrated consistent resolution above 1.8 within ±1.5 percent organic modifier, ±2 °C column temperature, and ±0.1 pH unit.

Benefits and Practical Applications

Automation reduced total development time to five days and minimized analyst intervention. The resulting method provides a fast, reproducible platform for routine quality control of mebendazole formulations and facilitates method transfer across laboratories.

Future Trends and Opportunities

Advances in artificial intelligence–driven parameter selection and real-time feedback loops promise further acceleration of UHPLC method development. Integration with predictive modelling may enable simultaneous multi-attribute analyses and more robust method transfers between diverse instrument platforms.

Conclusion

The combination of ChromSword Chromeleon Connect and Vanquish Flex UHPLC enabled a fully automated, rapid, and robust method for analyzing mebendazole and related impurities. This systematic approach significantly reduces time and labor while delivering high-quality analytical separation suitable for pharmaceutical quality assurance.

Reference

Park SH, De Pra M, Grosse S, Paul C, Valenta A, Steiner F. Automated UHPLC method development for mebendazole and related impurities, from method scouting to robustness testing. Thermo Fisher Scientific; 2022.